Journal article
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
Abstract
BACKGROUND: Liver biopsy is considered as the gold standard for assessing nonalcoholic fatty liver disease (NAFLD) histologic lesions in patients with morbid obesity. The aim of this study was to determine the diagnostic utility of noninvasive markers of fibrosis (FibroTest), steatosis (SteatoTest), and steatohepatitis (NashTest, ActiTest) in these patients.
MATERIALS AND METHODS: Two hundred and eighty-eight patients presenting with …
Authors
Lassailly G; Caiazzo R; Hollebecque A; Buob D; Leteurtre E; Arnalsteen L; Louvet A; Pigeyre M; Raverdy V; Verkindt H
Journal
European Journal of Gastroenterology & Hepatology, Vol. 23, No. 6, pp. 499–506
Publisher
Wolters Kluwer
Publication Date
6 2011
DOI
10.1097/meg.0b013e3283464111
ISSN
0954-691X